Close Menu

NEW YORK (GenomeWeb) — Fulgent Genetics reported after the close of the market on Tuesday a 15 percent increase in its first quarter revenues.

For the three-month period ended March 31, Fulgent posted revenues of $5.4 million versus $4.7 million in the same quarter last year. The firm said it delivered 7,530 billable genetic tests during Q1, a 63 percent year-over-year increase.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.